Medifast (MED) Operating Expenses (2010 - 2026)

Medifast (MED) has 17 years of Operating Expenses data on file, last reported at $55.1 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Expenses fell 35.62% year-over-year to $55.1 million; the trailing twelve-month figure through Mar 2026 stood at $258.9 million (down 36.52% YoY), and the FY2025 full-year result was $289.4 million, down 34.49% from the prior year.
• Operating Expenses for Q1 2026 stood at $55.1 million, down from $59.9 million in the prior quarter.
• Across five years, Operating Expenses topped out at $272.7 million in Q2 2022 and bottomed at $55.1 million in Q1 2026.
• The 5-year median for Operating Expenses is $131.3 million (2024), against an average of $140.7 million.
• The widest annual swing landed in 2022, when Operating Expenses climbed 26.28%; it then sank 40.82% in 2025.
• A 5-year view of Operating Expenses shows it stood at $201.0 million in 2022, then slumped by 33.98% to $132.7 million in 2023, then plunged by 34.05% to $87.5 million in 2024, then plunged by 31.5% to $59.9 million in 2025, then fell by 8.16% to $55.1 million in 2026.
• The last three Operating Expenses figures came in at $55.1 million (Q1 2026), $59.9 million (Q4 2025), and $66.2 million (Q3 2025), per Business Quant data.

Peer Comparison